| 2020 |
Towler OW, Shore EM, Kaplan FS. Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva. Bone. January 2020;130:115116. |
4 |
0 |
| 2020 |
Pignolo RJ, Cheung K, Kile S, Fitzpatrick MA, De Cunto C, Al Mukaddam M, Hsiao EC, Baujat G, Delai P, Eekhoff EMW, Di Rocco M, Grunwald Z, Haga N, Keen R, Levi B, Morhart R, Scott C, Sherman A, Zhang K, Kaplan FS. Self-reported baseline phenotypes from the international fibrodysplasia ossificans progressiva (fop) association global registry. Bone. May 2020;134:115274. |
3 |
0 |
| 2020 |
Kaplan FS, Al Mukaddam M, Stanley A, Towler OW, Shore EM. Fibrodysplasia ossificans progressiva (FOP): a disorder of osteochondrogenesis. Bone. November 2020;140:115539. |
1 |
1 |
| 2021 |
Wang H, De Cunto CL, Pignolo RJ, Kaplan FS. Spatial patterns of heterotopic ossification in fibrodysplasia ossificans progressiva correlate with anatomic temperature gradients. Bone. August 2021;149:115978. |
0 |
0 |
| 2021 |
Kaplan FS, Teachey DT, Andolina JR, Siegel DM, Mancilla EE, Hsiao EC, Al Mukaddam M, Rocke DM, Pignolo RJ. Off-on-off-on use of imatinib in three children with fibrodysplasia ossificans progressiva. Bone. September 2021;150:116016. |
0 |
0 |
| 2023 |
Pignolo RJ, Kimel M, Whalen J, Kawata AK, Artyomenko A, Kaplan FS. The Fibrodysplasia Ossificans Progressiva Physical Function Questionnaire (FOP-PFQ): a patient-reported, disease-specific measure. Bone. March 2023;168:116642. |
0 |
0 |
| 1992 |
Barth RW, Williams JL, Kaplan FS. Osteon morphometry in females with femoral neck fractures. Clin Orthop Relat Res. October 1992;283:178-186. |
28 |
27 |
| 2016 |
Pignolo RJ, Bedford-Gay C, Liljesthröm M, Durbin-Johnson BP, Shore EM, Rocke DM, Kaplan FS. The natural history of flare-ups in fibrodysplasia ossificans progressiva (FOP): a comprehensive global assessment. J Bone Miner Res. March 2016;31(3):650-656. |
11 |
1 |
| 2022 |
Wang H, Zhang Q, Kaplan FS, Pignolo RJ. Clearance of senescent cells from injured muscle abrogates heterotopic ossification in mouse models of fibrodysplasia ossificans progressiva. J Bone Miner Res. January 2022;37(1):95-107. |
1 |
1 |
| 2022 |
Pignolo RJ, McCarrick-Walmsley R, Wang H, Qiu S, Hunter J, Barr S, He K, Zhang H, Kaplan FS. Plasma-soluble biomarkers for fibrodysplasia ossificans progressiva (FOP) reflect acute and chronic inflammatory states. J Bone Miner Res. March 2022;37(3):475-483. |
0 |
0 |
| 2022 |
Pignolo RJ, Baujat G, Hsiao EC, Keen R, Wilson A, Packman J, Strahs AL, Grogan DR, Kaplan FS. Palovarotene for fibrodysplasia ossificans progressiva (FOP): results of a randomized, placebo-controlled, double-blind phase 2 trial. J Bone Miner Res. October 2022;37(10):1891-1902. |
1 |
0 |
| 2022 |
Wentworth KL, Lalonde RL, Groppe JC, Brewer N, Moody T, Hansberry S, Taylor KE, Shore EM, Kaplan FS, Pignolo RJ, Yelick PC, Hsiao EC. Functional testing of bone morphogenetic protein (BMP) pathway variants identified on whole-exome sequencing in a patient with delayed-onset fibrodysplasia ossificans progressiva (FOP) using ACVR1R206H-specific human cellular and zebrafish models. J Bone Miner Res. November 2022;37(11):2058-2076. |
1 |
1 |
| 2023 |
Pignolo RJ, Hsiao EC, Mukaddam MA, Baujat G, Berglund SK, Brown MA, Cheung AM, Cunto CD, Delai P, Haga N, Kannu P, Keen R, Sang K-HLQ, Mancilla EE, Marino R, Strahs A, Kaplan FS. Reduction of new heterotopic ossification (HO) in the open-label, phase 3 MOVE trial of palovarotene for fibrodysplasia ossificans progressiva (FOP). J Bone Miner Res. March 2023;38(3):381-394. |
0 |
0 |
| 2006 |
Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho T-J, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. May 2006;38(5):525-528. |
36 |
24 |
| 1991 |
Grisso JA, Kelsey JL, Strom BL, Chiu GY, Maislin G, O'Brien LA, Hoffman S, Kaplan F; Northeast Hip Fracture Study Group. Risk factors for falls as a cause of hip fracture in women. NEJM. May 9, 1991;324(19):1326-1331. |
69 |
67 |